Categories
Healthcare Science

Infinity BiologiX (‘IBX’), a leader in analytics, bioprocessing and biobanking receives accreditation from College of American Pathologists

PISCATAWAY, N.J. — (BUSINESS WIRE) — Infinity BiologiX, LLC (IBX).

The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to IBX, Piscataway, New Jersey Laboratory, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

 

Chief Scientific Officer, Shareef Nahas, PHD, was advised of this national recognition and congratulated for the excellence of the services being provided. IBX is one of more than 8,000 CAP-accredited facilities worldwide.

 

“With CAP inspections every three years, renewing this accreditation is always an important milestone for IBX and we’re incredibly proud to receive this news. It represents the ongoing efforts of our team and how well placed we are to support our clients with the breadth of experience we have in biobanking and the management of biospecimens,” said Nahas.

 

Robin Grimwood, CEO at IBX, said: “Maintaining high quality and standards as we more than double the size of our biorepository is essential for our clients and their samples. We know biospecimens are integral to improving patient outcomes and demand for biobanking services to support precision medicine is greater than ever. At IBX we see the standards set by CAP, which draws on best practices from ISBER, NCI, OECD, CMS, as vital to our mission to be the lab behind every transformative health innovation.”

 

About the College of American Pathologists: As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.

 

About Infinity BiologiX (IBX): IBX is a market-disrupting next-generation central laboratory supporting academia, government, and industry. IBX provides global sample collection, processing, storage, and analytical services integrated with scientific and technical support in both the research and clinical arenas. As a leader in biomaterials, IBX provides support to the development of diagnostics, therapeutics, and research in the genomics, precision, and regenerative medicine arenas. IBX previously operated as RUCDR Infinite Biologics before spinning off from Rutgers University-New Brunswick in August 2020.

 

For more information, please visit www.ibx.bio.

Contacts

Media: Mike Thurogood Mike.thurogood@infinity-biologix.com

Categories
Business Lifestyle

Manasquan Bank selects Bakkt to offer retail clients access to cryptocurrency

Manasquan Bank modernizes its digital banking offerings by expanding access for clients to buy, sell and hold cryptocurrencies

ALPHARETTA, Ga. — (BUSINESS WIRE) — Bakkt Holdings, Inc. (NYSE: BKKT), a trusted digital asset platform that enables consumers to buy, sell, send and spend a range of digital assets, today announced that Manasquan Bank, a NJ-based mutual community bank with total consolidated assets of $2.7 billion, will be participating in its early adopter program, which, when effective, will allow the bank’s retail clients to buy, sell and hold cryptocurrency through the bank’s mobile banking app.

Manasquan Bank will be making cryptocurrency access simple and approachable within the digital banking environment their clients know and trust, while ensuring the bank is participating in this expanding space with the opportunity to break into new audience segments. Bakkt’s modern digital asset platform allows banks to plug and play a crypto buy/sell/hold module which provides end clients with a seamless set up and quick access to multiple cryptocurrencies. Bakkt leverages a regulatory-first approach to safely and securely custody these assets.

 

“This is an incredible opportunity to provide Manasquan Bank clients with an entry point to adopt cryptocurrency as an additional asset option,” said Sheela Zemlin, Chief Revenue Officer, Bakkt. “It’s clear that cryptocurrency is the center of the Web3 economy, in which consumers can participate in new value creation and exchange with digital assets. Bakkt is proud to roll out new and innovative ways to this burgeoning economy, enabling a path to buy, sell and hold crypto as an extension of the consumer’s relationship with their trusted local bank.”

 

“We’re focused on driving growth and introducing new opportunities for our clients to participate in the digital economy,” said James Vaccaro, Chair, President and Chief Executive Officer of Manasquan Bank. “Our developing partnership with Bakkt to introduce these new offerings and features comes at an exciting time when consumers continue to seek out crypto assets as an option for the acquisition of a portfolio of cryptocurrencies even if it is in very small increments to start, and without having to leave their existing, trusted banking environment.”

 

Bakkt’s early adopter program is anticipated to launch in Q2 2022 and the bank’s participation is contingent upon the adoption by the bank’s core financial service provider.

 

About Bakkt:

Bakkt is a trusted digital asset platform that enables consumers to buy, sell, store and spend digital assets. Bakkt’s platform, now available through the Bakkt App and to partners, amplifies consumer spending and bolsters loyalty programs, adding value for all key stakeholders within the Bakkt payments and digital assets ecosystem. Launched in 2018, Bakkt is headquartered in Alpharetta, GA. For more information, visit: https://www.bakkt.com/ | Twitter @Bakkt | LinkedIn https://www.linkedin.com/company/bakkt/

 

Bakkt-C

Source: Bakkt Holdings, Inc.

 

About Manasquan Bank:

Manasquan Bank, a mutual community bank with consolidated assets of $2.7 billion, is headquartered in Wall Township, NJ. The Bank has been serving New Jersey residents since 1874 and continues to pioneer the future of banking with both traditional and digital solutions. The bank offers a full line of personal & business services, and operates fifteen branch locations throughout Middlesex, Monmouth & Ocean Counties. Manasquan Bank proudly supports community-focused, non-profit initiatives through the Manasquan Bank Charitable Foundation. For more information, visit www.manasquan.bank.

Contacts

Bakkt Media Contact
Lauren Post, VP – Communications

Lauren.Post@bakkt.com

Manasquan Bank Contacts
James Vaccaro – Chair, President and Chief Executive Officer of Manasquan Bank

jvaccaro@manasquan.bank

Categories
Business Healthcare

Global Pharma Tek celebrates 10-year anniversary

EDISON, N.J. — (BUSINESS WIRE) — #ClinicalResearch–Global Pharma Tek (GPT), a service provider conglomerate in Workforce, Clinical Research and Trading with presence in USA, Canada, India and Europe, is celebrating its 10th anniversary.

Global Pharma Tek was founded by Ramesh Anumolu in 2011, with a great vision of helping individuals with the right skills find employment in the right companies. “This is an incredible milestone. The past 10 years have been an extraordinary journey for Global Pharma Tek, going from a team of few employees to a few hundred,” said Ramesh Anumolu, CEO, Global Pharma Tek. “As we celebrate our 10th anniversary this year, our hearts are filled with gratitude and the zest to keep innovating, to build faster and smarter future. We continue to explore opportunities and expand our global footprint, we ensure non-negotiable adherence to globally accepted compliance standards to further strengthen our policies and make our systems and processes more robust.”

 

A History of Growth and Innovation

From its starting point of a young team of 5 members, the team now consists of 200+ employees spread across the globe.

 

For over 10 years, Global Pharma Tek’s people-focused, performance-driven culture has helped hundreds of men and women find rewarding work at leading companies. The company very well understands the fact that an exceptional workforce demands both capability and character.

 

At present, the company is focusing on everything on what it has learned from the workers who form the backbone of our economy. As per Ramesh Anumolu, “Whether you work in the IT, Healthcare, Pharma, Manufacturing, Warehousing, Facilities & Maintenance or that matter any industry, we know you’re looking for more than just a job or a worker. My vision is as simple today as it was over 10 years ago — connecting great talent and great organizations. Our drive is to empower people to achieve career success.”

 

About Global Pharma Tek

Global Pharma Tek, founded in 2011 with the presence in USA, India, Canada and Europe, is a service provider conglomerate in Workforce, Clinical Research and Trading. The company is renowned for setting unique benchmarks in technology, research, design, quality and has embraced innovation to build a better and promising future.

 

Know More @ www.globalpharmatek.com

Contacts

Bhavani Shankar

shankar@globalpharmatek.com

Categories
Business Technology

Infobip saw record breaking eCommerce activity during Cyber Week processing 4.23 billion messages for some of the world’s most popular brands

JERSEY CITY, N.J. — (BUSINESS WIRE) — Global cloud communications company, Infobip this year processed an unprecedented total of 2.26bn interactions across all channels including SMS, voice, email, push and Chat Apps for Black Friday, and 1.97 bn on Cyber Monday for customers across the globe.


It accounts for a 71% increase in network activity compared to 2020 with SMS the most used channel, clocking up a 51% increase in use from last year. In total 1.7bn SMS texts were sent over this period.

 

Cyber Monday client interactions almost doubled this year with a 93% increase compared to 2020.

 

MMS and Chat Apps also saw huge uptake with gains over last year of 87% and 86% respectively. Overall, Black Friday interactions doubled in 2021 to 2.26bn up from 1.3bn in 2020. India and North America dominated by volume of interactions while revenues were highest in North America and Europe.

 

Izabel Jelenic, Chief Technology Officer at Infobip says: “Shopping this year appears to have been spread over Cyber Week, encouraged in part by retailers that have been publicizing Black Friday style deals since October. Nevertheless, overall, the popularity of this shopping week has grown exponentially since last year, very possibly due to customers having become very used to transacting online since the pandemic started. Another factor contributing to shoppers having gotten a head start on their gift buying this year were the ongoing concerns around bottlenecks in the global supply chain and fears of finding merchandise out of stock.”

 

A survey carried out by Attentive Mobile iwith over 4000 of its own client base shows over 1 billion text messages were sent during Cyber Week by the world’s most loved brands generating sales of over $830 million from SMS alone. These included campaign and automated messages such as abandonment reminders that drove an average of 34.6% conversion rate. Similarly, campaign messages such as flash sales and discounts saw a 9% conversion rate showing subscribers were actively engaging with favorite brands through text.

 

For some organizations, a large proportion of total business for the year comes in the last quarter. These figures indicate that retailers will end 2021 on a high.

 

About Infobip:

Infobip is a global cloud communications platform that enables businesses to build connected experiences across all stages of the customer journey. Accessed through a single platform, Infobip’s omnichannel engagement, identity, user authentication and contact center solutions help businesses and partners overcome the complexity of consumer communications to grow business and increase loyalty. With over a decade of industry experience, Infobip has expanded to 65+ offices across six continents. It offers natively built technology with the capacity to reach over seven billion mobile devices and ‘things’ in 190+ countries connected directly to over 650 telecom networks.

 

Infobip was established in 2006 and is led by its co-founders, CEO Silvio Kutić, Roberto Kutić and Izabel Jelenić.

 

Recent award wins include:

  • Infobip named a Leader in the IDC MarketScape: Worldwide Communications Platform-as-a-Service (CPaaS) 2021 Vendor Assessment (May 2021).
  • Best A2P SMS provider for the fourth year running by mobile operators and enterprises in ROCCO’s annual Messaging Vendor Benchmarking Report
  • Best CPaaS Provider of the Year, Best RCS Provider of the Year, and Mover & Shaker in Telco Innovation at the 2021 Juniper Research Future Digital Awards

 


i Cyber Week 2021 Recap: Brands Generated $830 Million From SMS, Doubling Revenue From 2020 – Text Talk | Attentive (attentivemobile.com)

Contacts

Media:

Janet Lennon

Brand & Communications Expert, Infobip

Direct: 206.914.6175

janet.lennon@infobip.com

Categories
Business

CORRECTING and REPLACING AM Best affirms credit ratings of Landcar Casualty Company

OLDWICK, N.J. — (BUSINESS WIRE) — #insurance–Third paragraph, first sentence of the release should read: The rating affirmations follow the close of the transaction, effective December 17, 2021, where Asbury has acquired Landcar as part of an acquisition that also includes the Larry H. Miller dealerships for approximately $3.2 billion (instead of …approximately $3.3 billion).

The updated release reads:

 

AM BEST AFFIRMS CREDIT RATINGS OF LANDCAR CASUALTY COMPANY

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Landcar Casualty Company (Landcar) (Sandy, UT), recently acquired by Asbury Automotive Group, Inc. (Asbury) [NYSE: ABG]. The outlook of these Credit Ratings (ratings) is stable.

 

The ratings reflect Landcar’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management (ERM).

 

The rating affirmations follow the close of the transaction, effective December 17, 2021, where Asbury has acquired Landcar as part of an acquisition that also includes the Larry H. Miller dealerships for approximately $3.2 billion. Asbury is a publicly traded Fortune 500 automotive retailer that is considered the fourth-largest automotive retailer in the United States. Immediate holding company, Asbury Automotive Group, LLC, will own 100% ownership of Landcar.

 

Landcar’s ratings are supported by its strongest risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR), and solid underwriting performance, as well as benefits derived from its niche profile as a writer of auto-related insurance products sold through a network of affiliated automotive dealerships under the Asbury group. Landcar’s neutral business profile, while experiencing some execution risk associated with expansion into additional states, is expected to support the Asbury’s organization by vertically integrating its finance and insurance products within the group. AM Best considers Landcar’s ERM to be appropriate, with policies and procedures in place for the business written. AM Best will monitor the expansion and the new parent’s use of the operating entity, as Landcar is expected to support its growth by focusing on staffing needs and integration opportunities within Asbury.

 

The stable outlooks reflect AM Best’s expectation that Landcar will maintain its balance sheet strength at the very strong level and its operating performance at the adequate level, while managing its strategic initiatives to expand its book of business as a result of the Asbury acquisition.

 

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

 

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

 

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Anthony Molinaro
Senior Financial Analyst
+1 908 439 2200, ext. 5608
anthony.molinaro@ambest.com

Vicky Riggs
Associate Director
+1 908 439 2200, ext. 5039
vicky.riggs@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Jim Peavy
Director, Communications
+1 908 439 2200, ext. 5644
james.peavy@ambest.com

Categories
Business Healthcare

SHAREHOLDER ALERT: Robbins LLP investigates Aquestive Therapeutics, Inc. (AQST) on behalf of shareholders

SAN DIEGO & WARREN, N.J. — (BUSINESS WIRE) — $AQST #Libervant–Shareholder rights law firm Robbins LLP is investigating Aquestive Therapeutics, Inc. (NASDAQ: AQST) to determine whether certain Aquestive officers and directors violated securities laws and breached their fiduciary duty to the Company. Aquestive is a specialty pharmaceutical company that develops products to address unmet medical needs. The Company’s most advanced proprietary product candidate is Libervant (diazepam), the first oral diazepam-based therapy for the treatment of recurrent epileptic seizures.

If you would like more information about Aquestive Therapeutics, Inc.’s misconduct, click here.

 

Aquestive Therapeutics, Inc. (AQST) May Have Misled Investors About the Likelihood of Approval of its New Drug Application for Libervant

According to a complaint filed on behalf of purchasers of Aquestive, on December 2, 2019, Aquestive announced the completion of the rolling submission of a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for Libervant Buccal Film for the management of seizure clusters (the “Libervant NDA”). During the relevant period, Aquestive expressed that the process for obtaining FDA approval was on target and “as expected.”

 

On September 25, 2019, Aquestive announced receipt of a Complete Response Letter from the FDA indicating that the review cycle for the Libervant NDA was complete but the application could not be approved in its current form. Aquestive informed shareholders, “the FDA cited that, in a study submitted by the Company with the NDA, certain weight groups showed a lower drug exposure level than desired. The Company intends to provide to the FDA additional information on PK modeling to demonstrate that dose adjustments will obtain the desired exposure levels.” On this News Aquestive’s stock price fell $2.64 per share, or over 34.69%, to close at $4.97 per share on September 28, 2020.

 

Aquestive Therapeutics, Inc. (AQST) shareholders have legal options. If you own shares of Aquestive Therapeutics, Inc., contact us for more information. All representation is on a contingency fee basis. Shareholders pay no fees or costs.

Contact us to learn more:

Lauren Levi

(800) 350-6003

llevi@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Aquestive Therapeutics, Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

 

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi

Robbins LLP

5040 Shoreham Place

San Diego, CA 92122

llevi@robbinsllp.com
(800) 350-6003

www.robbinsllp.com

Categories
Business Lifestyle

Thompson Street Capital Partners portfolio company Len The Plumber acquires Russo Bros.

ST. LOUIS — (BUSINESS WIRE) — Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced its portfolio company Len The Plumber (LTP), a leading full-service residential home services company based in Baltimore, Maryland, with branches serving the Mid-Atlantic region, has completed the acquisition of Russo Bros. Russo Bros. is a full-service provider of residential HVAC, plumbing, electrical and indoor air quality services located in East Hanover, New Jersey. Founded in 1954, Russo Bros. serves three counties in northern New Jersey. Russo Bros.’ Co-Owner, Matt Russo, will stay on post-close and continue to run the business, while Co-Owner, Mark Russo, will support the business for a transitional period and subsequently retire. Terms of the transaction were not disclosed.

Jeff Cooper, CEO of LTP, said, “Russo Bros. was identified as a key partner to help us expand our residential services in the New Jersey market. Matt and Mark have grown a family business with a long history into a successful company with a great team, experienced technicians, and a high standard of customer service. We are looking forward to building on these efforts as we work together to drive growth into the future.”

 

Jeff Aiello, TSCP Managing Director, added, “We are very enthusiastic to partner with Russo Bros. Matt and Mark have built an impressive business which complements our Len The Plumber platform nicely in terms of both service lines and geographies. I look forward to seeing what these two businesses can accomplish together.”

 

About Thompson Street Capital Partners

Thompson Street Capital Partners (www.tscp.com) is a St. Louis-based private equity firm focused on investing in founder-led middle market businesses in the Life Sciences & Healthcare, Software & Technology, and Business and Consumer Services and Products sectors. TSCP partners with management teams to increase value by accelerating growth, both organically and via acquisitions.

Contacts

Caroline Collins

BackBay Communications

617-963-0065

caroline.collins@backbaycommunications.com

Categories
Business News Now!

BTRS Holdings Inc. announces expiration and results of exchange offer and consent solicitation relating to its warrants

LAWRENCEVILLE, N.J. — (BUSINESS WIRE) — BTRS Holdings Inc. (“Billtrust” or the “Company”) (NASDAQ: BTRS), a B2B accounts receivable (AR) automation and integrated payments leader, announced today the expiration and results of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding warrants, each whole warrant exercisable for one share of Class 1 Common Stock, $0.0001 par value per share (“Common Stock”), of the Company, at an exercise price of $11.50 per share (the “Warrants”). The Offer and Consent Solicitation expired one minute after 11:59 p.m., Eastern Standard Time, on December 16, 2021.

 

The Company has been advised that 12,391,408 Warrants (including 30,171 Warrants tendered through guaranteed delivery), or approximately 99.2% of the outstanding Warrants, were validly tendered and not validly withdrawn prior to the expiration of the Offer and Consent Solicitation. The Company expects to accept all validly tendered Warrants for exchange and settlement on or before December 21, 2021.

 

In addition, pursuant to the Consent Solicitation, the Company received the approval of approximately 99.2% of the outstanding Warrants to amend the warrant agreement that governs the Warrants (the “Warrant Amendment”), which exceeds the 50% of the outstanding Warrants required to effect the Warrant Amendment. Accordingly, the Company and Continental Stock Transfer & Trust Company entered into the Warrant Amendment, dated December 17, 2021, and the Company announced that it will exercise its right to exchange all remaining outstanding Warrants for shares of Common Stock in accordance with the terms of the Warrant Amendment, and has fixed December 31, 2021 as the exchange date.

 

The Company also announced that its Registration Statement on Form S-4 filed with the U.S. Securities and Exchange Commission (the “SEC”) registering shares of Common Stock issuable in the Offer was declared effective by the SEC on December 16, 2021.

 

BofA Securities, Inc. was the Dealer Manager for the Offer and Consent Solicitation. D.F. King & Co., Inc. served as the Information Agent for the Offer and Consent Solicitation, and Continental Stock Transfer & Trust Company served as the Exchange Agent.

 

About Billtrust

Billtrust (NASDAQ: BTRS) is a leading provider of cloud-based software and integrated payment processing solutions that simplify and automate B2B commerce. Accounts receivable is broken and relies on conventional processes that are outdated, inefficient, manual and largely paper based. Billtrust is at the forefront of the digital transformation of accounts receivable, providing mission-critical solutions that span credit decisioning and monitoring, online ordering, invoice delivery, payments and remittance capture, cash application and collections.

 

No Offer or Solicitation

This press release shall not constitute an offer to exchange or the solicitation of an offer to exchange or the solicitation of an offer to purchase any securities, nor shall there be any exchange or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. A Registration Statement on Form S-4 filed with the SEC registering shares of Common Stock issuable in the Offer was declared effective by the SEC on December 16, 2021.

 

Forward-Looking Statements

Certain statements made in this press release are “forward-looking statements.” Forward-looking statements may be identified by the use of words such as “expect,” “will” or other similar expressions that predict or indicate future events that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding Billtrust’s acceptance of all validly tendered Warrants for exchange of shares of Common Stock in the Offer and settlement thereof and the subsequent exercise of Billtrust’s right to exchange the remaining outstanding Warrants pursuant to the Warrant Amendment. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Billtrust’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions. Many actual events and circumstances are beyond the control of Billtrust. These forward-looking statements are subject to a number of risks and uncertainties, including Billtrust’s ability to successfully exchange the remaining Warrants pursuant to the Warrant Amendment; Billtrust’s ability to attract and retain customers and expand customers’ use of Billtrust’s services; market, financial, political and legal conditions; the impact of the COVID-19 pandemic on Billtrust’s business and the global economy; risks relating to the uncertainty of the projected financial and operating information with respect to Billtrust; risks related to future market adoption of Billtrust’s offerings; risks related to Billtrust’s marketing and growth strategies; risks related to expanding Billtrust’s operations outside the United States; risks related to Billtrust’s ability to acquire or invest in businesses, products, or technologies that may complement or expand its products or platforms, enhance its technical capabilities, or otherwise offer growth opportunities; the effects of competition on Billtrust’s future business; and the risks discussed in Billtrust’s Prospectus/Exchange Offer filed with the SEC on December 16, 2021, under the heading “Risk Factors” and other documents of Billtrust filed, or to be filed, with the SEC. If any of these risks materialize or any of Billtrust’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Billtrust presently does not know of or that Billtrust currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Billtrust’s expectations, plans or forecasts of future events and views as of the date of this press release. Billtrust anticipates that subsequent events and developments will cause Billtrust’s assessments to change. However, while Billtrust may elect to update these forward-looking statements at some point in the future, Billtrust specifically disclaims any obligation to do so, except as may be required by law. These forward-looking statements should not be relied upon as representing Billtrust’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Contacts

Investor:

John T. Williams

IR@billtrust.com

Categories
Business News Now!

AM Best affirms credit ratings of Brighthouse Financial Inc. and its subsidiaries

OLDWICK, N.J. — (BUSINESS WIRE) — AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” (Excellent) of Brighthouse Life Insurance Company (headquartered in Charlotte, NC), New England Life Insurance Company (Boston, MA) and Brighthouse Life Insurance Company of NY (New York, NY). These entities collectively are referred to as Brighthouse and are operating insurance subsidiaries of Brighthouse Financial, Inc. (Brighthouse Financial) (headquartered in Charlotte, NC) [NASDAQ: BHF]. The outlook of these Credit Ratings (rating) is stable.

Concurrently, AM Best has affirmed the Long-Term ICR of “bbb+” (Good) and the Long-Term Issue Credit Ratings (Long-Term IR) of Brighthouse Financial, Inc. Additionally, AM Best has affirmed the Long-Term ICR of “bbb+” (Good) and the Long-Term IR of Brighthouse Holdings, LLC, Brighthouse Financial’s intermediate holding company. The outlook of these ratings is stable. (See below for a detailed listing of the Long-Term IRs).

 

The ratings reflect Brighthouse’s balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management (ERM).

 

Brighthouse maintains a very strong level of risk-adjusted capital, as measured by Best’s Capital Adequacy Ratio (BCAR), in line with prior years. Capital and surplus has fluctuated on a statutory and GAAP basis over the most recent five-year period, partially driven by variable annuity reform. Mitigating the fluctuation of capital are Brighthouse’s good financial flexibility, good liquidity and access to available cash at the holding company.

 

As of year-end 2020, Brighthouse reported a net operating loss, which was attributable to unfavorable market conditions. Despite a prior-year loss, the company has reported a strong earnings recovery as of third-quarter 2021. The company’s flagship annuity product – Brighthouse Shield Level Annuity – has grown significantly over recent years and accounts for a majority of the company’s annuity sales, allowing Brighthouse to remain a major participant in the registered index-linked annuities marketplace. Partially offsetting the growth of the annuity business is Brighthouse’s run-off of legacy life and annuity businesses. Additionally, on the life insurance side, Brighthouse has entered into the hybrid indexed universal life space with Brighthouse SmartCare.

 

Brighthouse’s favorable business profile is indicative of the continued improvement of the company’s brand, product and geographic diversification, as well as its strategic alliance with BlackRock. Collaborating with BlackRock provides Brighthouse with the capability to provide its consumers with simplified access to lifetime income. The company remains highly sensitive to the macroeconomic environment.

 

Brighthouse’s ERM program is well-developed and appropriate for its risk profile.

 

The following Long-Term IRs have been affirmed with stable outlooks:

 

Brighthouse Financial, Inc.

— “bbb+” (Good) on $1.5 billion 3.7% senior unsecured notes, due 2027

— “bbb+” (Good) on $615 million 5.625% senior unsecured notes, due 2030

— “bbb+” (Good) on $1.5 billion 4.7% senior unsecured notes, due 2047

— “bbb+” (Good) on $400 million 3.85% senior unsecured notes, due 2051

— “bbb-” (Good) on $350 million 4.625% non-cumulative preferred stock

— “bbb-” (Good) on $375 million 6.25% junior subordinated debentures, due 2058

— “bbb-” (Good) on $425 million 6.6% non-cumulative preferred stock, Series A

— “bbb-” (Good) on $402.5 million 6.75% non-cumulative preferred stock, Series B

— “bbb-” (Good) on $575 million 5.375% non-cumulative preferred stock, Series C

Brighthouse Holdings, LLC

— “bbb-” (Good) on $50 million fixed rate cumulative preferred units, Series A

The following Long-Term IR has been affirmed with a stable outlook:

Brighthouse Financial Institutional Funding I, LLC—“a+” (Excellent) program rating

— “a+” (Excellent) on outstanding notes issued under the program rating

The following indicative Long-Term IRs have been affirmed with stable outlooks:

Brighthouse Financial, Inc.-

— “bbb+” (Good) on senior unsecured debt

— “bbb” (Good) on subordinated debt

— “bbb-” (Good) on preferred stock

— “bbb-” (Good) on junior subordinated debt

 

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

 

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

 

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Shauna Nelson
Senior Financial Analyst
+1 908 439 2200, ext. 5365
shauna.nelson@ambest.com

Bruno Caron
Associate Director
+1 908 439 2200, ext. 5144
bruno.caron@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Jim Peavy
Director, Communications
+1 908 439 2200, ext. 5644
james.peavy@ambest.com

Categories
Business

INSERTING and REPLACING ArculusTM brings the next generation of crypto security to bitcoin 2022

Arculus partners with the world’s largest Bitcoin conference to distribute 25,000 crypto security cards during the April event in Miami Beach, Florida

 

SOMERSET, N.J. — (BUSINESS WIRE) — $DBDR #3FA–Insert at end of second paragraph, first sentence of release dated December 15, 2021: and CompoSecure, which recently announced it had signed a merger agreement with Roman DBDR Tech Acquisition Corp. (NASDAQ: DBDR) (“Roman DBDR”), a special purpose acquisition company.

The updated release reads:

 

ARCULUSTM BRINGS THE NEXT GENERATION OF CRYPTO SECURITY TO BITCOIN 2022

Arculus partners with the world’s largest Bitcoin conference to distribute 25,000 crypto security cards during the April event in Miami Beach, Florida

 

CompoSecure Holdings, L.L.C. (“CompoSecure”), a leading provider of premium financial payment cards and an emergent provider of cryptocurrency storage and security solutions, today announced its Arculus business has partnered with Bitcoin 2022 to provide each of the estimated 25,000 conference attendees a custom-designed Arculus Key™ Card crypto security solution.

 

“Crypto is going mainstream and Bitcoin 2022 attendees, among the savviest crypto market participants, will lead the way to secure their crypto,” said Adam Lowe, Chief Innovation Officer of Arculus and CompoSecure, which recently announced it had signed a merger agreement with Roman DBDR Tech Acquisition Corp. (NASDAQ: DBDR) (“Roman DBDR”), a special purpose acquisition company. “As more people buy cryptocurrencies, hacks are expected to continue to rise, and Arculus, which literally means ‘strong box,’ is positioned to become the new standard in securing an individual’s digital assets.”

 

The Arculus Key Card and Arculus WalletTM App work together with a one-of-a-kind 3-factor authentication security solution to make it simple, safe and secure to store, buy, swap, send and receive cryptocurrency.

 

“The Arculus Card is a new cold storage product that we are excited to get in the hands of everyone attending the largest Bitcoin event in the world.” said David Bailey, CEO of BTC Media, “BTC works hard to educate our audience on the very best innovation on the market to protect their digital assets, and allow for easier use for the largest community.”

 

Your Arculus Card uses a secure element to store your encrypted private keys, meaning your crypto keys remain in your possession. Transactions require three factors of authentication combining:

 

  • Something You Are – Your app will authenticate with your unique biometrics.
  • Something You Know – Your app will ask you to input your private 6-digit PIN.
  • Something You Have – Your Arculus Key Card contains an EAL 6+ embedded secure element that holds your encrypted private keys. Simply tap the card to your phone to complete your transaction.

 

The new co-branded Bitcoin 2022 Arculus Key Card to be distributed at the Miami Beach event in April 2022 is an example of a non-custodial private key management solution offering the Arculus Key Card and Arculus Wallet App’s security, privacy and ease of use. Whale Pass attendee (VIPs with added benefits at the conference) will receive an exclusively designed, limited-edition Bitcoin 2022 Arculus Whale Key Card. Cryptocurrency exchanges, financial institutions and other fintechs can add their own branding for a best-in-class white-label solution, offering their customers safe storage of their cryptocurrency.

 

On November 30, 2021, CompoSecure and Roman DBDR announced a special meeting of Roman DBDR stockholders to consider matters related to the proposed business combination with CompoSecure. The meeting will be held on December 23, 2021 at 10:00 a.m., Eastern Time, in a virtual format. Roman DBDR stockholders may attend and vote at the Special Meeting by visiting https://www.cstproxy.com/romandbdr/sm2021 and entering the control number found on their proxy card, voting instruction form or notice included in their proxy materials.

 

More information about voting and attending the Special Meeting is included in the definitive proxy statement filed by Roman DBDR with the Securities and Exchange Commission (the “SEC”) on November 30, 2021, which is available without charge on the SEC’s website at http://www.sec.gov or https://www.romandbdr.com/investor-relations.

 

About CompoSecure and Arculus

Founded in 2000, CompoSecure is a pioneer and category leader in premium payment cards and an emergent provider of cryptocurrency and digital asset storage and security solutions. The company focuses on serving the affluent customers of payment card issuers worldwide using proprietary production methods that meet the highest standards of quality and security. The company offers secure, innovative, and durable proprietary products that implement leading-edge engineering capabilities and security. CompoSecure’s mission is to increase clients’ brand equity in the marketplace by offering products and solutions which differentiate the brands they represent, thus elevating cardholder experience. For more information, please visit www.composecure.com. ArculusTM was created with the mission to promote cryptocurrency adoption by making it safe, simple and secure for the average person to store, buy, swap, send and receive cryptocurrency. With a strong background in security hardware and financial payments, the ArculusTM solution was developed to allow people to use a familiar payment card form factor to manage their cryptocurrency. For more information, please visit www.GetArculus.com.

 

About Roman DBDR Tech Acquisition Corp.

Roman DBDR is a special purpose acquisition company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. While the company may pursue an initial business combination target in any stage of its corporate evolution or in any industry or sector, it intends to focus its search on companies in the technology, media and telecom (“TMT”) industries. The company is led by its Co-Chief Executive Officers, Dr. Donald G. Basile and Dixon Doll, Jr. The company’s experienced board of directors includes former NVCA Chairman and longtime venture capitalist Dixon Doll, Global Net Lease (NYSE: GNL) CEO James L. Nelson, former fund manager Paul Misir, investment banker and investor Arun Abraham, and entrepreneur Alan Clingman. For more information, please visit www.romandbdr.com Roman DBDR raised $236 million in its initial public offering (inclusive of underwriter’s exercise of over-allotment option) in November 2020 and is listed on Nasdaq under the symbol “DBDR.”

 

Forward-Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to statements regarding Roman DBDR’s or CompoSecure’s expectations, hopes, beliefs, intentions or strategies regarding the future, including, without limitation, statements regarding: (i) the ability of Roman DBDR and CompoSecure to complete the proposed merger described in the Press Release, (ii) the size, demand and growth potential of the markets for CompoSecure’s products and CompoSecure’s ability to serve those markets, (iii) the degree of market acceptance and adoption of CompoSecure’s products, (iv) CompoSecure’s ability to develop innovative products and compete with other companies engaged in the financial services and technology industry, and (v) CompoSecure’s ability to attract and retain clients. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether or not identified in this Press Release, and on the current expectations of CompoSecure’s and Roman DBDR’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, a prediction or a definitive statement of fact or probability. Neither Roman DBDR nor CompoSecure gives any assurance that either Roman DBDR or CompoSecure will achieve its expectations. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of CompoSecure and Roman DBDR. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond Roman DBDR’s and CompoSecure’s control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These factors include, among others: the inability to complete the proposed merger; the inability to recognize the anticipated benefits of the proposed merger, including due to the failure to receive required security holder approvals, or the failure of other closing conditions; and costs related to the proposed merger. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the definitive proxy statement on Schedule 14A (the “Proxy Statement”) relating to the proposed merger filed by Roman DBDR with the U.S. Securities and Exchange Commission (the “SEC”) and other documents filed by Roman DBDR from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that none of Roman DBDR or CompoSecure presently know or that Roman DBDR or CompoSecure currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Roman DBDR’s and CompoSecure’s expectations, plans or forecasts of future events and views as of the date of this Press Release. Roman DBDR and CompoSecure anticipate that subsequent events and developments will cause Roman DBDR’s and CompoSecure’s assessments to change. However, while Roman DBDR and CompoSecure may elect to update these forward-looking statements at some point in the future, Roman DBDR and CompoSecure specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Roman DBDR’s and CompoSecure’s assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. Certain market data information in this Press Release is based on the estimates of CompoSecure and Roman DBDR management.

 

Additional Information about the Proposed Merger and Where to Find It

In connection with the proposed merger, Roman DBDR has filed a definitive proxy statement with the SEC. The documents relating to the proposed merger can be obtained free of charge from the SEC’s website at www.sec.gov. These documents can also be obtained free of charge by contacting CompoSecure at: Marc P. Griffin, ICR for CompoSecure, 646-277-1290, CompoSecure-IR@icrinc.com.

 

Participants in the Solicitation

This communication is not a solicitation of a proxy from any security holder of Roman DBDR. CompoSecure, Roman DBDR and our respective directors, executive officers, other members of management and employees may be deemed to be participants in the solicitation of proxies from Roman DBDR’s stockholders in connection with the proposed merger. Information regarding the names and interests in the proposed merger of Roman DBDR’s directors and officers is contained Roman DBDR’s filings with the SEC. Additional information regarding the interests of potential participants in the solicitation process has also been included in the definitive proxy statement relating to the proposed merger and other relevant documents filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

Contacts

Media Contact:

Wes Robinson

310-824-9000

wrobinson@olmsteadwilliams.com